Hon. Chief Physician and Director of Nuclear Medicine,

Over the past decade the availability of new investigational tools including genetically modified mouse models of human disease, has resulted in a clearer understanding of the molecular mechanisms of many important human diseases such as hypertension, diabetes mellitus, atherosclerosis, neurodegenerative diseases and cancer. Biotechnology has provided monoclonal antibodies, peptides